Stable Isotope Dilution LC-HRMS Assay To Determine Free SN-38, Total SN-38, and SN-38G in a Tumor Xenograft Model after Intravenous Administration of Antibody–Drug Conjugate (Sacituzumab Govitecan)-Reference-Cited by-同舟云学术

Stable Isotope Dilution LC-HRMS Assay To Determine Free SN-38, Total SN-38, and SN-38G in a Tumor Xenograft Model after Intravenous Administration of Antibody–Drug Conjugate (Sacituzumab Govitecan)

Published:2019-11-25 Issue:1 Volume:92 Page:1260-1267
ISSN:0003-2700
Container-title:Analytical Chemistry
language:en
Short-container-title:Anal. Chem.

Author:

Pandey Renu,Gruslova Aleksandra,Chiou Jennifer,Brenner Andrew J.,Tiziani Stefano^ORCID

Funder

University of Texas System

Publisher

American Chemical Society (ACS)

Subject

Analytical Chemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.analchem.9b04419

Reference22 articles.

1. Antibody–drug conjugates for cancer therapy

2. Antibody-Drug Conjugate-Based Therapeutics: State of the Science

3. First-in-Human Trial of a Novel Anti-Trop-2 Antibody-SN-38 Conjugate, Sacituzumab Govitecan, for the Treatment of Diverse Metastatic Solid Tumors

4. Enhanced Delivery of SN-38 to Human Tumor Xenografts with an Anti-Trop-2–SN-38 Antibody Conjugate (Sacituzumab Govitecan)

5. Sacituzumab govitecan (IMMU-132), an anti-Trop-2-SN-38 antibody-drug conjugate for the treatment of diverse epithelial cancers: Safety and pharmacokinetics

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. LC-MS/MS method for dual-ligand peptide-drug CBP-1018 and its deconjugated payload MMAE including sample stabilization strategy for its MC-Val-Cit-PABC linker;Talanta;2024-11

2. Sacituzumab Govitecan in patients with breast cancer brain metastases and recurrent glioblastoma: a phase 0 window-of-opportunity trial;Nature Communications;2024-08-07

3. Preclinical evidence for the use of anti‐Trop‐2 antibody‐drug conjugate Sacituzumab govitecan in cerebral metastasized castration‐resistant prostate cancer;Cancer Medicine;2024-06

4. Precise construction of hyaluronic acid (HA)-coated drug-loaded iron oxide metal–organic frameworks: Investigation of cell death mechanism in neuroblastoma carcinoma cells;Journal of Materials Research;2024-01-08

5. Targeting Trop-2 in cancer: Recent research progress and clinical application;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2023-07